GenomeNet

Database: UniProt
Entry: Q5DW34
LinkDB: Q5DW34
Original site: Q5DW34 
ID   EHMT1_MOUSE             Reviewed;        1296 AA.
AC   Q5DW34; A2AIS3; A2AIS4; Q5EBR1; Q6PGM0;
DT   08-MAR-2011, integrated into UniProtKB/Swiss-Prot.
DT   08-MAR-2011, sequence version 2.
DT   04-NOV-2026, entry version 169.
DE   RecName: Full=Histone-lysine N-methyltransferase EHMT1;
DE            EC=2.1.1.- {ECO:0000269|PubMed:15774718, ECO:0000269|PubMed:24196706};
DE            EC=2.1.1.367 {ECO:0000269|PubMed:15774718};
DE   AltName: Full=Euchromatic histone-lysine N-methyltransferase 1;
DE            Short=Eu-HMTase1;
DE   AltName: Full=G9a-like protein 1;
DE            Short=GLP;
DE            Short=GLP1;
DE   AltName: Full=Lysine N-methyltransferase 1D;
GN   Name=Ehmt1 {ECO:0000303|PubMed:24196706, ECO:0000312|MGI:MGI:1924933};
GN   Synonyms=Euhmtase1, Glp, Kmt1d;
OS   Mus musculus (Mouse).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Mus; Mus.
OX   NCBI_TaxID=10090;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), FUNCTION, CATALYTIC ACTIVITY,
RP   SUBCELLULAR LOCATION, DISRUPTION PHENOTYPE, INTERACTION WITH EHMT2, AND
RP   TISSUE SPECIFICITY.
RX   PubMed=15774718; DOI=10.1101/gad.1284005;
RA   Tachibana M., Ueda J., Fukuda M., Takeda N., Ohta T., Iwanari H.,
RA   Sakihama T., Kodama T., Hamakubo T., Shinkai Y.;
RT   "Histone methyltransferases G9a and GLP form heteromeric complexes and are
RT   both crucial for methylation of euchromatin at H3-K9.";
RL   Genes Dev. 19:815-826(2005).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=C57BL/6J;
RX   PubMed=19468303; DOI=10.1371/journal.pbio.1000112;
RA   Church D.M., Goodstadt L., Hillier L.W., Zody M.C., Goldstein S., She X.,
RA   Bult C.J., Agarwala R., Cherry J.L., DiCuccio M., Hlavina W., Kapustin Y.,
RA   Meric P., Maglott D., Birtle Z., Marques A.C., Graves T., Zhou S.,
RA   Teague B., Potamousis K., Churas C., Place M., Herschleb J., Runnheim R.,
RA   Forrest D., Amos-Landgraf J., Schwartz D.C., Cheng Z., Lindblad-Toh K.,
RA   Eichler E.E., Ponting C.P.;
RT   "Lineage-specific biology revealed by a finished genome assembly of the
RT   mouse.";
RL   PLoS Biol. 7:E1000112-E1000112(2009).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 34-1296 (ISOFORM 2), AND
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 89-1296 (ISOFORM 3).
RC   STRAIN=C57BL/6J; TISSUE=Brain;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [4]
RP   FUNCTION, AND MUTAGENESIS OF TYR-1153; 1198-ASN--CYS-1201; CYS-1201 AND
RP   TYR-1240.
RX   PubMed=18818694; DOI=10.1038/emboj.2008.192;
RA   Tachibana M., Matsumura Y., Fukuda M., Kimura H., Shinkai Y.;
RT   "G9a/GLP complexes independently mediate H3K9 and DNA methylation to
RT   silence transcription.";
RL   EMBO J. 27:2681-2690(2008).
RN   [5]
RP   DOMAIN ANK REPEATS, AND INTERACTION WITH RELA.
RX   PubMed=21131967; DOI=10.1038/ni.1968;
RA   Levy D., Kuo A.J., Chang Y., Schaefer U., Kitson C., Cheung P., Espejo A.,
RA   Zee B.M., Liu C.L., Tangsombatvisit S., Tennen R.I., Kuo A.Y., Tanjing S.,
RA   Cheung R., Chua K.F., Utz P.J., Shi X., Prinjha R.K., Lee K., Garcia B.A.,
RA   Bedford M.T., Tarakhovsky A., Cheng X., Gozani O.;
RT   "Lysine methylation of the NF-kappaB subunit RelA by SETD6 couples activity
RT   of the histone methyltransferase GLP at chromatin to tonic repression of
RT   NF-kappaB signaling.";
RL   Nat. Immunol. 12:29-36(2011).
RN   [6]
RP   RETRACTED PAPER.
RX   PubMed=22629437; DOI=10.1371/journal.pone.0037647;
RA   Wang J., Abate-Shen C.;
RT   "The MSX1 homeoprotein recruits G9a methyltransferase to repressed target
RT   genes in myoblast cells.";
RL   PLoS ONE 7:e37647-e37647(2012).
RN   [7]
RP   RETRACTION NOTICE OF PUBMED:22629437.
RX   PubMed=37405986; DOI=10.1371/journal.pone.0288411;
RG   PLOS ONE Editors;
RL   PLoS ONE 18:e0288411-e0288411(2023).
RN   [8]
RP   FUNCTION, SUBCELLULAR LOCATION, INTERACTION WITH PRDM16, AND MUTAGENESIS OF
RP   1198-ASN-HIS-1199.
RX   PubMed=24196706; DOI=10.1038/nature12652;
RA   Ohno H., Shinoda K., Ohyama K., Sharp L.Z., Kajimura S.;
RT   "EHMT1 controls brown adipose cell fate and thermogenesis through the
RT   PRDM16 complex.";
RL   Nature 504:163-167(2013).
RN   [9] {ECO:0000305}
RP   FUNCTION, AND INTERACTION WITH BAZ2B.
RX   PubMed=32103178; DOI=10.1038/s41586-020-2037-y;
RA   Yuan J., Chang S.Y., Yin S.G., Liu Z.Y., Cheng X., Liu X.J., Jiang Q.,
RA   Gao G., Lin D.Y., Kang X.L., Ye S.W., Chen Z., Yin J.A., Hao P., Jiang L.,
RA   Cai S.Q.;
RT   "Two conserved epigenetic regulators prevent healthy ageing.";
RL   Nature 579:118-122(2020).
RN   [10]
RP   FUNCTION, AND INTERACTION WITH PRDM16.
RX   PubMed=35978186; DOI=10.1038/s41586-022-05067-4;
RA   Wang Q., Li H., Tajima K., Verkerke A.R.P., Taxin Z.H., Hou Z., Cole J.B.,
RA   Li F., Wong J., Abe I., Pradhan R.N., Yamamuro T., Yoneshiro T.,
RA   Hirschhorn J.N., Kajimura S.;
RT   "Post-translational control of beige fat biogenesis by PRDM16
RT   stabilization.";
RL   Nature 609:151-158(2022).
CC   -!- FUNCTION: Histone methyltransferase that specifically mono-, di- and
CC       trimethylates 'Lys-9' of histone H3 (H3K9me1, H3K9me2 and H3K9me3,
CC       respectively) in euchromatin (PubMed:15774718, PubMed:24196706). H3K9me
CC       represents a specific tag for epigenetic transcriptional repression by
CC       recruiting HP1 proteins to methylated histones (PubMed:15774718,
CC       PubMed:24196706). Also weakly methylates 'Lys-27' of histone H3
CC       (H3K27me) (PubMed:15774718). Also required for DNA methylation, the
CC       histone methyltransferase activity is not required for DNA methylation,
CC       suggesting that these 2 activities function independently
CC       (PubMed:18818694). Probably targeted to histone H3 by different DNA-
CC       binding proteins like E2F6, MGA, MAX and/or DP1 (By similarity). During
CC       G0 phase, it probably contributes to silencing of MYC- and E2F-
CC       responsive genes, suggesting a role in G0/G1 transition in cell cycle
CC       (By similarity). Involved in the differentiation of myoblastic
CC       precursors into brown adipose cells: following recruitment to chromatin
CC       by PRDM16, mediates formation of H3K9me2 and H3K9me3, inhibiting the
CC       expression of white adipose-selective genes (PubMed:24196706). Also
CC       involved in the differentiation of beige adipocytes from white adipose
CC       cells following recruitment by PRDM16 (PubMed:35978186). EHMT1 also
CC       promotes protein stabilization of PRDM16, by preventing PRDM16
CC       ubiquitination and degradation (PubMed:24196706). In addition to the
CC       histone methyltransferase activity, also methylates non-histone
CC       proteins: mediates dimethylation of 'Lys-373' of p53/TP53 (By
CC       similarity). Represses the expression of mitochondrial function-related
CC       genes, perhaps by occupying their promoter regions, working in concert
CC       with probable chromatin reader BAZ2B (PubMed:32103178).
CC       {ECO:0000250|UniProtKB:Q9H9B1, ECO:0000269|PubMed:15774718,
CC       ECO:0000269|PubMed:18818694, ECO:0000269|PubMed:24196706,
CC       ECO:0000269|PubMed:32103178, ECO:0000269|PubMed:35978186}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=L-lysyl(9)-[histone H3] + S-adenosyl-L-methionine = N(6)-
CC         methyl-L-lysyl(9)-[histone H3] + S-adenosyl-L-homocysteine + H(+);
CC         Xref=Rhea:RHEA:60280, Rhea:RHEA-COMP:15542, Rhea:RHEA-COMP:15546,
CC         ChEBI:CHEBI:15378, ChEBI:CHEBI:29969, ChEBI:CHEBI:57856,
CC         ChEBI:CHEBI:59789, ChEBI:CHEBI:61929; EC=2.1.1.367;
CC         Evidence={ECO:0000269|PubMed:15774718};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:60281;
CC         Evidence={ECO:0000269|PubMed:15774718};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=N(6)-methyl-L-lysyl(9)-[histone H3] + S-adenosyl-L-methionine
CC         = N(6),N(6)-dimethyl-L-lysyl(9)-[histone H3] + S-adenosyl-L-
CC         homocysteine + H(+); Xref=Rhea:RHEA:60284, Rhea:RHEA-COMP:15541,
CC         Rhea:RHEA-COMP:15542, ChEBI:CHEBI:15378, ChEBI:CHEBI:57856,
CC         ChEBI:CHEBI:59789, ChEBI:CHEBI:61929, ChEBI:CHEBI:61976;
CC         Evidence={ECO:0000269|PubMed:15774718, ECO:0000269|PubMed:24196706};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:60285;
CC         Evidence={ECO:0000269|PubMed:15774718, ECO:0000269|PubMed:24196706};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=N(6),N(6)-dimethyl-L-lysyl(9)-[histone H3] + S-adenosyl-L-
CC         methionine = N(6),N(6),N(6)-trimethyl-L-lysyl(9)-[histone H3] + S-
CC         adenosyl-L-homocysteine + H(+); Xref=Rhea:RHEA:60288, Rhea:RHEA-
CC         COMP:15538, Rhea:RHEA-COMP:15541, ChEBI:CHEBI:15378,
CC         ChEBI:CHEBI:57856, ChEBI:CHEBI:59789, ChEBI:CHEBI:61961,
CC         ChEBI:CHEBI:61976; Evidence={ECO:0000269|PubMed:24196706};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:60289;
CC         Evidence={ECO:0000269|PubMed:24196706};
CC   -!- ACTIVITY REGULATION: Methyltransferase activity is inhibited by BIX-
CC       01294. Efficiently inhibited by compound E72, a BIX-01294 derivative in
CC       which the diazepane ring and the benzyl are replaced with a 3-
CC       dimethylaminopropyl and a 5-aminopentyl group at sites B and C,
CC       respectively (By similarity). {ECO:0000250|UniProtKB:Q9H9B1}.
CC   -!- SUBUNIT: Interacts with WIZ. Part of the E2F6.com-1 complex in G0 phase
CC       composed of E2F6, MGA, MAX, TFDP1, CBX3, BAT8, EHMT1, RING1, RNF2,
CC       MBLR, L3MBTL2 and YAF2. Interacts with MPHOSPH8 (By similarity).
CC       Interacts with CDYL. Interacts with REST only in the presence of CDYL.
CC       Part of a complex containing at least CDYL, REST, WIZ, SETB1, EHMT1 and
CC       EHMT2 (By similarity). Heterodimer; heterodimerizes with EHMT2.
CC       Interacts (via ANK repeats) with RELA (when monomethylated at 'Lys-
CC       310'). Interacts with BAZ2B (PubMed:32103178). Interacts with PRDM16;
CC       promoting EHMT1 recruitment to chromatin, differentiation of brown
CC       adipose cells and stabilization of PRDM16 (PubMed:24196706,
CC       PubMed:35978186). {ECO:0000250|UniProtKB:Q9H9B1,
CC       ECO:0000269|PubMed:15774718, ECO:0000269|PubMed:21131967,
CC       ECO:0000269|PubMed:24196706, ECO:0000269|PubMed:32103178,
CC       ECO:0000269|PubMed:35978186}.
CC   -!- INTERACTION:
CC       Q5DW34-1; A2A935-3: Prdm16; NbExp=2; IntAct=EBI-16080518, EBI-16080455;
CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:15774718}. Chromosome
CC       {ECO:0000269|PubMed:15774718, ECO:0000269|PubMed:24196706}.
CC       Note=Associates with euchromatic regions.
CC       {ECO:0000269|PubMed:15774718}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=3;
CC       Name=1;
CC         IsoId=Q5DW34-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q5DW34-2; Sequence=VSP_040724, VSP_040725;
CC       Name=3;
CC         IsoId=Q5DW34-3; Sequence=VSP_040726;
CC   -!- TISSUE SPECIFICITY: Ubiquitous. {ECO:0000269|PubMed:15774718}.
CC   -!- DOMAIN: The ANK repeats specifically recognize and bind H3K9me1 and
CC       H3K9me2 (By similarity). They also specifically recognize and bind RELA
CC       subunit of NF-kappa-B, when RELA is monomethylated at 'Lys-310'
CC       (PubMed:21131967). {ECO:0000250|UniProtKB:Q9H9B1,
CC       ECO:0000269|PubMed:21131967}.
CC   -!- DOMAIN: The SET domain mediates interaction with WIZ.
CC       {ECO:0000250|UniProtKB:Q9H9B1}.
CC   -!- DOMAIN: In the pre-SET domain, Cys residues bind 3 zinc ions that are
CC       arranged in a triangular cluster; some of these Cys residues contribute
CC       to the binding of two zinc ions within the cluster.
CC       {ECO:0000250|UniProtKB:Q9H9B1}.
CC   -!- DISRUPTION PHENOTYPE: Embryos die around E9.5. Levels of H3K9me1 and
CC       H3K9me2 are drastically reduced (PubMed:15774718). Conditional deletion
CC       in brown adipocytes precursors causes a severe loss of brown fat and
CC       induces muscle differentiation through demethylation of H3K9me2 and
CC       H3K9me3 (PubMed:24196706). {ECO:0000269|PubMed:15774718,
CC       ECO:0000269|PubMed:24196706}.
CC   -!- SIMILARITY: Belongs to the class V-like SAM-binding methyltransferase
CC       superfamily. {ECO:0000255|PROSITE-ProRule:PRU00190}.
CC   -!- CAUTION: Thought to interact with MSX1. However the paper has been
CC       retracted over concerns of image tampering.
CC       {ECO:0000305|PubMed:37405986}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=CAM22112.1; Type=Erroneous initiation; Note=Truncated N-terminus.; Evidence={ECO:0000305};
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AB205007; BAD90007.1; -; mRNA.
DR   EMBL; AL732525; CAM22112.1; ALT_INIT; Genomic_DNA.
DR   EMBL; AL732525; CAM22113.1; -; Genomic_DNA.
DR   EMBL; AL732525; CAM22114.1; -; Genomic_DNA.
DR   EMBL; BC056938; AAH56938.1; -; mRNA.
DR   EMBL; BC089302; AAH89302.1; -; mRNA.
DR   CCDS; CCDS15740.1; -. [Q5DW34-1]
DR   CCDS; CCDS59634.1; -. [Q5DW34-2]
DR   CCDS; CCDS59636.1; -. [Q5DW34-3]
DR   RefSeq; NP_001012536.2; NM_001012518.3. [Q5DW34-1]
DR   RefSeq; NP_001103156.1; NM_001109686.2. [Q5DW34-2]
DR   RefSeq; NP_001103157.1; NM_001109687.2. [Q5DW34-3]
DR   AlphaFoldDB; Q5DW34; -.
DR   SMR; Q5DW34; -.
DR   BioGRID; 218847; 24.
DR   DIP; DIP-49000N; -.
DR   DIP; DIP-59572N; -.
DR   FunCoup; Q5DW34; 5089.
DR   IntAct; Q5DW34; 11.
DR   STRING; 10090.ENSMUSP00000119057; -.
DR   GlyCosmos; Q5DW34; 1 site, No reported glycans.
DR   GlyGen; Q5DW34; 2 sites, 1 O-linked glycan (1 site).
DR   iPTMnet; Q5DW34; -.
DR   PhosphoSitePlus; Q5DW34; -.
DR   SwissPalm; Q5DW34; -.
DR   jPOST; Q5DW34; -.
DR   PaxDb; 10090-ENSMUSP00000119057; -.
DR   PeptideAtlas; Q5DW34; -.
DR   ProteomicsDB; 277570; -. [Q5DW34-1]
DR   ProteomicsDB; 277571; -. [Q5DW34-2]
DR   ProteomicsDB; 277572; -. [Q5DW34-3]
DR   Pumba; Q5DW34; -.
DR   Antibodypedia; 32511; 547 antibodies from 35 providers.
DR   DNASU; 77683; -.
DR   Ensembl; ENSMPUT00000015409; ENSMPUP00000015170; ENSMPUG00000015280.
DR   Ensembl; ENSMUST00000046227.12; ENSMUSP00000046077.6; ENSMUSG00000036893.19. [Q5DW34-3]
DR   Ensembl; ENSMUST00000114432.9; ENSMUSP00000110075.3; ENSMUSG00000036893.19. [Q5DW34-2]
DR   Ensembl; ENSMUST00000147147.8; ENSMUSP00000119057.3; ENSMUSG00000036893.19. [Q5DW34-1]
DR   GeneID; 77683; -.
DR   KEGG; mmu:77683; -.
DR   UCSC; uc008iph.4; mouse. [Q5DW34-3]
DR   UCSC; uc008ipi.4; mouse. [Q5DW34-1]
DR   UCSC; uc012brr.3; mouse. [Q5DW34-2]
DR   AGR; MGI:1924933; -.
DR   CTD; 79813; -.
DR   MGI; MGI:1924933; Ehmt1.
DR   VEuPathDB; HostDB:ENSMUSG00000036893; -.
DR   eggNOG; KOG1082; Eukaryota.
DR   GeneTree; ENSGT00940000156002; -.
DR   HOGENOM; CLU_005790_3_0_1; -.
DR   InParanoid; Q5DW34; -.
DR   OMA; ACLCWKD; -.
DR   OrthoDB; 5792673at2759; -.
DR   PhylomeDB; Q5DW34; -.
DR   BRENDA; 2.1.1.367; 3474.
DR   BRENDA; 2.1.1.368; 3474.
DR   Reactome; R-MMU-2559582; Senescence-Associated Secretory Phenotype (SASP).
DR   Reactome; R-MMU-3214841; PKMTs methylate histone lysines.
DR   Reactome; R-MMU-6804760; Regulation of TP53 Activity through Methylation.
DR   Reactome; R-MMU-8953750; Transcriptional Regulation by E2F6.
DR   BioGRID-ORCS; 77683; 20 hits in 86 CRISPR screens.
DR   PRO; PR:Q5DW34; -.
DR   Proteomes; UP000000589; Chromosome 2.
DR   RNAct; Q5DW34; protein.
DR   Bgee; ENSMUSG00000036893; Expressed in manus and 230 other cell types or tissues.
DR   ExpressionAtlas; Q5DW34; baseline and differential.
DR   GO; GO:0000785; C:chromatin; IDA:UniProtKB.
DR   GO; GO:0005694; C:chromosome; EXP:UniProtKB.
DR   GO; GO:0016604; C:nuclear body; ISO:GO_Central.
DR   GO; GO:0005654; C:nucleoplasm; ISO:GO_Central.
DR   GO; GO:0005634; C:nucleus; IDA:UniProtKB.
DR   GO; GO:0070742; F:C2H2 zinc finger domain binding; IPI:UniProtKB.
DR   GO; GO:0046976; F:histone H3K27 methyltransferase activity; IDA:UniProtKB.
DR   GO; GO:0140942; F:histone H3K9 dimethyltransferase activity; IDA:UniProtKB.
DR   GO; GO:0046974; F:histone H3K9 methyltransferase activity; IDA:UniProtKB.
DR   GO; GO:0140948; F:histone H3K9 monomethyltransferase activity; EXP:UniProtKB.
DR   GO; GO:0140949; F:histone H3K9 trimethyltransferase activity; IDA:UniProtKB.
DR   GO; GO:0140947; F:histone H3K9me2 methyltransferase activity; EXP:UniProtKB.
DR   GO; GO:0008168; F:methyltransferase activity; ISO:GO_Central.
DR   GO; GO:0002039; F:p53 binding; ISO:GO_Central.
DR   GO; GO:0016279; F:protein-lysine N-methyltransferase activity; ISO:GO_Central.
DR   GO; GO:0001222; F:transcription corepressor binding; ISO:GO_Central.
DR   GO; GO:0008270; F:zinc ion binding; IEA:InterPro.
DR   GO; GO:0160274; P:beige fat cell differentiation; IDA:UniProtKB.
DR   GO; GO:0050873; P:brown fat cell differentiation; IDA:UniProtKB.
DR   GO; GO:0006325; P:chromatin organization; ISO:GO_Central.
DR   GO; GO:0006346; P:DNA methylation-dependent constitutive heterochromatin formation; IDA:UniProtKB.
DR   GO; GO:0040029; P:epigenetic regulation of gene expression; IBA:GO_Central.
DR   GO; GO:0140718; P:facultative heterochromatin formation; IDA:GO_Central.
DR   GO; GO:0045892; P:negative regulation of DNA-templated transcription; IMP:UniProtKB.
DR   GO; GO:0051148; P:negative regulation of muscle cell differentiation; IDA:UniProtKB.
DR   GO; GO:0000122; P:negative regulation of transcription by RNA polymerase II; IMP:MGI.
DR   GO; GO:0160275; P:negative regulation of white fat cell differentiation; IDA:UniProtKB.
DR   GO; GO:0018027; P:peptidyl-lysine dimethylation; IMP:UniProtKB.
DR   GO; GO:0018026; P:peptidyl-lysine monomethylation; IMP:UniProtKB.
DR   GO; GO:0120162; P:positive regulation of cold-induced thermogenesis; IMP:YuBioLab.
DR   GO; GO:0050821; P:protein stabilization; IDA:UniProtKB.
DR   GO; GO:0045995; P:regulation of embryonic development; IMP:UniProtKB.
DR   CDD; cd20905; EHMT_ZBD; 1.
DR   CDD; cd10535; SET_EHMT1; 1.
DR   FunFam; 2.170.270.10:FF:000005; Euchromatic histone-lysine N-methyltransferase 2; 1.
DR   FunFam; 1.25.40.20:FF:000029; histone-lysine N-methyltransferase EHMT1 isoform X2; 1.
DR   Gene3D; 1.25.40.20; Ankyrin repeat-containing domain; 1.
DR   Gene3D; 2.170.270.10; SET domain; 1.
DR   InterPro; IPR002110; Ankyrin_rpt.
DR   InterPro; IPR036770; Ankyrin_rpt-contain_sf.
DR   InterPro; IPR043550; EHMT1/EHMT2.
DR   InterPro; IPR047762; EHMT_CRR.
DR   InterPro; IPR007728; Pre-SET_dom.
DR   InterPro; IPR001214; SET_dom.
DR   InterPro; IPR046341; SET_dom_sf.
DR   InterPro; IPR038035; SET_EHMT1.
DR   PANTHER; PTHR46307; G9A, ISOFORM B; 1.
DR   PANTHER; PTHR46307:SF2; HISTONE-LYSINE N-METHYLTRANSFERASE EHMT1; 1.
DR   Pfam; PF12796; Ank_2; 2.
DR   Pfam; PF13637; Ank_4; 1.
DR   Pfam; PF21533; EHMT1-2_CRR; 1.
DR   Pfam; PF05033; Pre-SET; 1.
DR   Pfam; PF00856; SET; 1.
DR   PRINTS; PR01415; ANKYRIN.
DR   SMART; SM00248; ANK; 7.
DR   SMART; SM00468; PreSET; 1.
DR   SMART; SM00317; SET; 1.
DR   SUPFAM; SSF48403; Ankyrin repeat; 1.
DR   SUPFAM; SSF82199; SET domain; 1.
DR   PROSITE; PS50297; ANK_REP_REGION; 1.
DR   PROSITE; PS50088; ANK_REPEAT; 5.
DR   PROSITE; PS50867; PRE_SET; 1.
DR   PROSITE; PS50280; SET; 1.
PE   1: Evidence at protein level;
KW   Acetylation; Alternative splicing; ANK repeat; Chromatin regulator;
KW   Chromosome; Isopeptide bond; Metal-binding; Methyltransferase; Nucleus;
KW   Phosphoprotein; Reference proteome; Repeat; S-adenosyl-L-methionine;
KW   Transferase; Ubl conjugation; Zinc.
FT   INIT_MET        1
FT                   /note="Removed"
FT                   /evidence="ECO:0000250|UniProtKB:Q9H9B1"
FT   CHAIN           2..1296
FT                   /note="Histone-lysine N-methyltransferase EHMT1"
FT                   /id="PRO_0000405844"
FT   REPEAT          735..764
FT                   /note="ANK 1"
FT   REPEAT          770..799
FT                   /note="ANK 2"
FT   REPEAT          803..832
FT                   /note="ANK 3"
FT   REPEAT          836..866
FT                   /note="ANK 4"
FT   REPEAT          870..899
FT                   /note="ANK 5"
FT   REPEAT          903..932
FT                   /note="ANK 6"
FT   REPEAT          936..965
FT                   /note="ANK 7"
FT   REPEAT          969..1002
FT                   /note="ANK 8"
FT   DOMAIN          1058..1121
FT                   /note="Pre-SET"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00157"
FT   DOMAIN          1124..1241
FT                   /note="SET"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00190"
FT   REGION          1..111
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          170..200
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          341..470
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          653..714
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          903..905
FT                   /note="Histone H3K9me binding"
FT                   /evidence="ECO:0000250|UniProtKB:Q9H9B1"
FT   REGION          1160..1179
FT                   /note="Interaction with histone H3"
FT                   /evidence="ECO:0000250|UniProtKB:Q9H9B1"
FT   REGION          1240..1243
FT                   /note="Interaction with histone H3"
FT                   /evidence="ECO:0000250|UniProtKB:Q9H9B1"
FT   REGION          1271..1296
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        14..31
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        77..89
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        97..106
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        342..360
FT                   /note="Acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        371..391
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        392..414
FT                   /note="Acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        438..450
FT                   /note="Basic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   BINDING         1060
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /ligand_label="1"
FT                   /evidence="ECO:0000250|UniProtKB:Q9H9B1"
FT   BINDING         1060
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /ligand_label="2"
FT                   /evidence="ECO:0000250|UniProtKB:Q9H9B1"
FT   BINDING         1062
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /ligand_label="1"
FT                   /evidence="ECO:0000250|UniProtKB:Q9H9B1"
FT   BINDING         1066
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /ligand_label="1"
FT                   /evidence="ECO:0000250|UniProtKB:Q9H9B1"
FT   BINDING         1066
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /ligand_label="3"
FT                   /evidence="ECO:0000250|UniProtKB:Q9H9B1"
FT   BINDING         1071
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /ligand_label="1"
FT                   /evidence="ECO:0000250|UniProtKB:Q9H9B1"
FT   BINDING         1073
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /ligand_label="2"
FT                   /evidence="ECO:0000250|UniProtKB:Q9H9B1"
FT   BINDING         1103
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /ligand_label="2"
FT                   /evidence="ECO:0000250|UniProtKB:Q9H9B1"
FT   BINDING         1103
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /ligand_label="3"
FT                   /evidence="ECO:0000250|UniProtKB:Q9H9B1"
FT   BINDING         1107
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /ligand_label="2"
FT                   /evidence="ECO:0000250|UniProtKB:Q9H9B1"
FT   BINDING         1109
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /ligand_label="3"
FT                   /evidence="ECO:0000250|UniProtKB:Q9H9B1"
FT   BINDING         1113
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /ligand_label="3"
FT                   /evidence="ECO:0000250|UniProtKB:Q9H9B1"
FT   BINDING         1134..1136
FT                   /ligand="S-adenosyl-L-methionine"
FT                   /ligand_id="ChEBI:CHEBI:59789"
FT                   /evidence="ECO:0000250|UniProtKB:Q9H9B1"
FT   BINDING         1171
FT                   /ligand="S-adenosyl-L-methionine"
FT                   /ligand_id="ChEBI:CHEBI:59789"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00190"
FT   BINDING         1198..1199
FT                   /ligand="S-adenosyl-L-methionine"
FT                   /ligand_id="ChEBI:CHEBI:59789"
FT                   /evidence="ECO:0000250|UniProtKB:Q9H9B1"
FT   BINDING         1201
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /ligand_label="4"
FT                   /evidence="ECO:0000250|UniProtKB:Q9H9B1"
FT   BINDING         1254
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /ligand_label="4"
FT                   /evidence="ECO:0000250|UniProtKB:Q9H9B1"
FT   BINDING         1255
FT                   /ligand="S-adenosyl-L-methionine"
FT                   /ligand_id="ChEBI:CHEBI:59789"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00190"
FT   BINDING         1256
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /ligand_label="4"
FT                   /evidence="ECO:0000250|UniProtKB:Q9H9B1"
FT   BINDING         1261
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /ligand_label="4"
FT                   /evidence="ECO:0000250|UniProtKB:Q9H9B1"
FT   SITE            1153
FT                   /note="Histone H3K9me binding"
FT                   /evidence="ECO:0000250|UniProtKB:Q9H9B1"
FT   MOD_RES         2
FT                   /note="N-acetylalanine"
FT                   /evidence="ECO:0000250|UniProtKB:Q9H9B1"
FT   MOD_RES         433
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q9H9B1"
FT   MOD_RES         481
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q9H9B1"
FT   MOD_RES         1046
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q9H9B1"
FT   CROSSLNK        23
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO1); alternate"
FT                   /evidence="ECO:0000250|UniProtKB:Q9H9B1"
FT   CROSSLNK        23
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2); alternate"
FT                   /evidence="ECO:0000250|UniProtKB:Q9H9B1"
FT   CROSSLNK        191
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0000250|UniProtKB:Q9H9B1"
FT   CROSSLNK        229
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0000250|UniProtKB:Q9H9B1"
FT   CROSSLNK        232
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0000250|UniProtKB:Q9H9B1"
FT   CROSSLNK        315
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0000250|UniProtKB:Q9H9B1"
FT   CROSSLNK        325
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0000250|UniProtKB:Q9H9B1"
FT   CROSSLNK        430
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0000250|UniProtKB:Q9H9B1"
FT   CROSSLNK        559
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0000250|UniProtKB:Q9H9B1"
FT   CROSSLNK        644
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0000250|UniProtKB:Q9H9B1"
FT   CROSSLNK        659
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0000250|UniProtKB:Q9H9B1"
FT   CROSSLNK        729
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0000250|UniProtKB:Q9H9B1"
FT   VAR_SEQ         273..279
FT                   /note="Missing (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:15489334"
FT                   /id="VSP_040724"
FT   VAR_SEQ         455..500
FT                   /note="Missing (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:15489334"
FT                   /id="VSP_040725"
FT   VAR_SEQ         550..597
FT                   /note="Missing (in isoform 3)"
FT                   /evidence="ECO:0000303|PubMed:15489334"
FT                   /id="VSP_040726"
FT   MUTAGEN         1153
FT                   /note="Y->V: In LM7; does not prevent methyltransferase
FT                   activity; when associated with F-1240."
FT                   /evidence="ECO:0000269|PubMed:18818694"
FT   MUTAGEN         1198..1201
FT                   /note="Missing: In LM3; does not form heterodimer with
FT                   EHMT2 and is defective in mediating both H3K9me and DNA
FT                   methylation."
FT                   /evidence="ECO:0000269|PubMed:18818694"
FT   MUTAGEN         1198..1199
FT                   /note="NH->LE: Abolished histone methyltransferase
FT                   activity, preventing differentiation of brown adipose
FT                   cells."
FT                   /evidence="ECO:0000269|PubMed:24196706"
FT   MUTAGEN         1201
FT                   /note="C->A: In LM4; does not prevent methyltransferase
FT                   activity."
FT                   /evidence="ECO:0000269|PubMed:18818694"
FT   MUTAGEN         1240
FT                   /note="Y->F: In LM7; does not prevent methyltransferase
FT                   activity; when associated with V-1153."
FT                   /evidence="ECO:0000269|PubMed:18818694"
FT   CONFLICT        411
FT                   /note="E -> D (in Ref. 1; BAD90007)"
FT                   /evidence="ECO:0000305"
SQ   SEQUENCE   1296 AA;  141999 MW;  B7783B6F38D3C7CB CRC64;
     MAAADAEQAV LAKQETKQDC CMKTELLRED TPMAADEGST EKQEGETPMA ADGETNGSCE
     KSGDPSHLNA PKHTQENTRA SPQEGTNRVS RVAENGVSER DTEVGKQNHV TADDFMQTSV
     IGSNGYFLNK PALQGQPLRT PNILTSSLPG HAAKTLPGGA SKCRTLSALP QTPTTAPTVP
     GEGSADTEDR KPTASGTDVR VHRARKTMPK SILGLHAASK DHREVQDHKE PKEDINRNIS
     ECGRQQLLPT FPALHQSLPQ NQCYMATTKS QTACLPFVLA AAVSRKKKRR MGTYSLVPKK
     KTKVLKQRTV IEMFKSITHS TVGAKGEKAL DDSALHVNGE SLEMDSEDED SDELEDDEDH
     GAEQAAAFPT EDSRTSKESM SETDRAAKMD GDSEEEQESP DTGEDEDGGD ESDLSSESSI
     KKKFLKRRGK TDSPWIKPAR KRRRRSRKKP SSMLGSEACK SSPGSMEQAA LGDSAGYMEV
     SLDSLDLRVR GILSSQTENE GLASGPDVLG TDGLQEVPLC SCRMETPKSR EISTLANNQC
     MATESVDHEL GRCTNSVVKY ELMRPSNKAP LLVLCEDHRG RMVKHQCCPG CGYFCTAGNF
     MECQPESSIS HRFHKDCASR VNNASYCPHC GEEASKAKEV TIAKADTTST VTLAPGQEKS
     LAAEGRADTT TGSIAGAPED ERSQSTAPQA PECFDPAGPA GLVRPTSGLS QGPGKETLES
     ALIALDSEKP KKLRFHPKQL YFSARQGELQ KVLLMLVDGI DPNFKMEHQS KRSPLHAAAE
     AGHVDICHML VQAGANIDTC SEDQRTPLME AAENNHLDAV KYLIKAGAQV DPKDAEGSTC
     LHLAAKKGHY DVVQYLLSNG QMDVNCQDDG GWTPMIWATE YKHVELVKLL LSKGSDINIR
     DNEENICLHW AAFSGCVDIA EILLAAKCDL HAVNIHGDSP LHIAARENRY DCVVLFLSRD
     SDVTLKNKEG ETPLQCASLS SQVWSALQMS KALRDSAPDK PVAVEKTVSR DIARGYERIP
     IPCVNAVDSE LCPTNYKYVS QNCVTSPMNI DRNITHLQYC VCVDDCSSST CMCGQLSMRC
     WYDKDGRLLP EFNMAEPPLI FECNHACSCW RNCRNRVVQN GLRARLQLYR TQDMGWGVRS
     LQDIPLGTFV CEYVGELISD SEADVREEDS YLFDLDNKDG EVYCIDARFY GNVSRFINHH
     CEPNLVPVRV FMSHQDLRFP RIAFFSTRLI QAGEQLGFDY GERFWDVKGK LFSCRCGSSK
     CRHSSAALAQ RQASAAQEPQ ENGLPDTSSA AAADPL
//
DBGET integrated database retrieval system